Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-12-25
pubmed:abstractText
Parkinson's disease is the most common neurodegenerative movement disorder and affects about 2% of the population over the age of 60 years. In 2004, mutations in the LRRK2 gene were first described and turned out to be the most frequent genetic cause of familial and sporadic Parkinson's disease and may account for up to 40% of patients in distinct populations. Based on these findings, Latourelle and colleagues show that the penetrance of the most common LRRK2 mutation is higher in patients with familial compared with sporadic Parkinson's disease and identified a substantial number of affected relatives of mutation carriers not presenting with a LRRK2 mutation themselves. This commentary discusses the role of genetic and/or environmental susceptibility factors modulating the expressivity of the disease trait, how these factors may contribute to the phenomenon of phenocopies in genetically defined Parkinson's disease pedigrees, and how the findings of Latourelle and colleagues, published this month in BMC Medicine, relate to current concepts of genetic counselling.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-10875828, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-12189225, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-15541308, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-15541309, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-15680456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16130111, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16251215, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16436781, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16436782, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16616379, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16769864, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16896109, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-16941458, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-17095157, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-17215492, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-17582365, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18162487, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18337586, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18447897, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18539534, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18539535, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18644660, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-18986508, http://linkedlifedata.com/resource/pubmed/commentcorrection/18986509-9197268
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1741-7015
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
33
pubmed:dateRevised
2010-9-23
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.
pubmed:affiliation
Laboratory of Functional Neurogenomics, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany. rejko.krueger@uni-tuebingen.de
pubmed:publicationType
Editorial, Comment, Research Support, Non-U.S. Gov't